I don't know how close everyone here follows the mmj market globally, but the extracts markets is growing faster than anything else marijuana related in North America.. If IGS begins producing extracts that yield a higher value of CBD on a mass scale the revenue could be massive. At $100,000 per KG and 20 acres yielding 2,000 kg's per annum at a claimed extremely low cost... I think the company could take over the industry in the blink of an eye. Massive commercial pharma opportunity here.
I'm a buy on this one for sure - especially @ $0.004
Thoughts here gents?
- MMJInvestor (..because we all love Green)
IGS Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held